U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C46H62N4O11
Molecular Weight 847.0047
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RIFABUTIN

SMILES

CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C4=C(C(=O)C(NC(=O)C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5NC6(CCN(CC(C)C)CC6)N=C45)C(O)=C3C

InChI

InChIKey=ATEBXHFBFRCZMA-VXTBVIBXSA-N
InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1

HIDE SMILES / InChI
Molecular Formula C46H62N4O11
Molecular Weight 847.0047
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:27:37 UTC 2023
Edited
by admin
on Fri Dec 15 16:27:37 UTC 2023
Record UNII
1W306TDA6S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RIFABUTIN
EP   HSDB   INN   JAN   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
INN   USAN  
Official Name English
LM-427
Code English
RIFABUTIN [VANDF]
Common Name English
LM 427
Code English
RIFABUTIN [ORANGE BOOK]
Common Name English
MYCOBUTIN
Code English
RIFABUTIN [USP-RS]
Common Name English
ANSAMYCIN
Common Name English
RIFABUTIN [JAN]
Common Name English
RIFABUTIN [EP MONOGRAPH]
Common Name English
RIFABUTIN COMPONENT OF TALICIA
Brand Name English
RIFABUTIN [MI]
Common Name English
1',4-DIDEHYDRO-1-DEOXY-1,4-DIHYDRO-5'-(2-METHYLPROPYL)-1-OXORIFAMYCIN XIV
Common Name English
rifabutin [INN]
Common Name English
Rifabutin [WHO-DD]
Common Name English
4-DEOXO-3,4-(2-SPIRO-(N-ISOBUTYL-4-PIPERIDYL))-(1H)-IMIDAZO-(2,5-DIHYDRO)RIFAMYCIN S
Common Name English
RIFABUTIN [USAN]
Common Name English
TALICIA COMPONENT RIFABUTIN
Brand Name English
4-N-ISOBUTYLSPIROPIPERIDYLRIFAMYCIN S
Common Name English
RIFABUTIN [HSDB]
Common Name English
RIFABUTIN [USP MONOGRAPH]
Common Name English
RIFABUTIN [MART.]
Common Name English
Classification Tree Code System Code
WHO-VATC QJ04AB04
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
NCI_THESAURUS C280
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
NDF-RT N0000007911
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
LIVERTOX NBK547975
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
NDF-RT N0000007911
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
NDF-RT N0000007911
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
NDF-RT N0000007911
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
FDA ORPHAN DRUG 41989
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
WHO-ATC J04AB04
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
FDA ORPHAN DRUG 770820
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
NDF-RT N0000175501
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 6.2.4
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
FDA ORPHAN DRUG 338811
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
FDA ORPHAN DRUG 41889
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
Code System Code Type Description
LACTMED
Rifabutin
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
WIKIPEDIA
RIFABUTIN
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
INN
5668
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
MERCK INDEX
m9608
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY Merck Index
PUBCHEM
6323490
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
RXCUI
55672
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY RxNorm
DRUG CENTRAL
2376
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
NCI_THESAURUS
C1408
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
MESH
D017828
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
DAILYMED
1W306TDA6S
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
SMS_ID
100000091607
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
EPA CompTox
DTXSID0033960
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
EVMPD
SUB10304MIG
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
FDA UNII
1W306TDA6S
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
CHEBI
45367
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
DRUG BANK
DB00615
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
HSDB
3577
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
RS_ITEM_NUM
1603800
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
USAN
FF-8
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
CAS
72559-06-9
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
ChEMBL
CHEMBL444633
Created by admin on Fri Dec 15 16:27:37 UTC 2023 , Edited by admin on Fri Dec 15 16:27:37 UTC 2023
PRIMARY
Related Record Type Details
CYTOCHROME P450 3A5
METABOLIC ENZYME -> INDUCER
CYTOCHROME P450 3A4
METABOLIC ENZYME -> INDUCER
MRP-2
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
Structure of 32-HYDROXYRIFABUTIN
METABOLITE -> PARENT
Structure of 25-O-DEACETYLRIFABUTIN
METABOLITE ACTIVE -> PARENT
MAJOR
Structure of 32-HYDROXY-25-O-DEACETYLRIFABUTIN
METABOLITE -> PARENT
Structure of 31-HYDROXYRIFABUTIN
METABOLITE -> PARENT
MAJOR
Related Record Type Details
Structure of RIFABUTIN N-OXIDE OPEN RING
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 3-AMINORIFAMYCIN S
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 1-ISOBUTYL-4-PIPERIDONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (TLC)
EP
Structure of RIFABUTIN 14R EPIMER
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of RIFABUTIN 21R EPIMER
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of RIFABUTIN N-OXIDE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 21,31-DIDEHYDRORIFABUTIN
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 3-AMINO-4-DEOXO-4-IMINORIFAMYCIN S
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 25-O-DEACETYLRIFABUTIN
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
Structure of RIFABUTIN
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966